These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10055)

  • 21. [The role of beta and alpha adrenergic receptors in the lipolytic effect of catecholamines on dog adipocytes (author's transl)].
    Berlan M; Dang Tran L
    J Physiol (Paris); 1978 Dec; 74(6):601-8. PubMed ID: 218001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].
    Constantin M; Beaughard M; Piris P; Labrid C
    J Pharmacol; 1981; 12(3):239-54. PubMed ID: 6116833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
    Bugajski J; Hano J; Zdebska A
    Pol J Pharmacol Pharm; 1978; 30(6):799-818. PubMed ID: 755244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of adrenergic blocking agents on plasma gastrin and secretin levels in man.
    Seino S; Seino Y; Taminato T; Mori K; Matsukura S; Yawata M; Imura H
    Am J Gastroenterol; 1980 Feb; 73(2):137-40. PubMed ID: 6104918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
    Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
    Márquez MT; Mikulić LE; Aramendía P
    Methods Find Exp Clin Pharmacol; 1981; 3(5):283-9. PubMed ID: 7329156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
    Taouis M; Berlan M; Montastruc P; Lafontan M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1172-80. PubMed ID: 2905003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cerebroventricular perfusion of alpha and beta adrenergic blocking agents on carotid occulsion response.
    Abraham GJ; Ahmed SS; Verghese KG
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):105-11. PubMed ID: 4394964
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of phenoxybenzamine and propranolol and their combination on the restoration of glucose homeostasis after insulin induced hypoglycemia.
    Cowell JW; Hetenyi G
    Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):412-22. PubMed ID: 4390993
    [No Abstract]   [Full Text] [Related]  

  • 32. Sympathomimetic amines and cardiac arrhythmias.
    Oppenheimer E; Akavia E; Shavit S; Korczyn AD
    Cardiovasc Res; 1990 Sep; 24(9):754-7. PubMed ID: 1977520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of beta-adrenergic blockade on lipid mobilization induced by fasting in dogs.
    Kozłowski S; Kowalik-Borówka E; Nazar K; Falecka-Wieczorek I; Stephens D; Kaciuba-Uściłko H
    Horm Metab Res; 1985 Jan; 17(1):8-11. PubMed ID: 2857149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha- and beta-receptor blockade of isoproterenol- and norepinephrine-induced effects on regional blood flow and blood flow acceleration.
    Immink WF; Beijer HJ; Charbon GA
    Eur J Pharmacol; 1978 Aug; 50(3):159-73. PubMed ID: 28954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The medial preoptic area modulates the increase in plasma glucose and free fatty acid mobilization induced by acute cold exposure.
    Ferreira ML; Marubayashi U; Coimbra CC
    Brain Res Bull; 1999 Jun; 49(3):189-93. PubMed ID: 10435782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free fatty acid mobilization in rats following intracerebroventricular norepinephrine.
    Barbosa MC; Migliorini RH
    Am J Physiol; 1982 Apr; 242(4):E248-52. PubMed ID: 7065239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects of catecholamines in sheep.
    Bassett JM
    Aust J Biol Sci; 1970 Aug; 23(4):903-14. PubMed ID: 4394518
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood levels, clearance rates and effects of epinephrine and norepinephrine on insulin and metabolites during alpha- and beta-adrenergic blockade in cattle in vivo, and in vitro degradation of dopamine in bovine blood.
    Fröhli D; Blum JW
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):245-53. PubMed ID: 2898856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of alpha- and beta-adrenergic agonists and blockers on postprandial pancreatic polypeptide release in dogs.
    Linnestad P; Guldvog I; Schrumpf E
    Scand J Gastroenterol; 1983 Jan; 18(1):87-90. PubMed ID: 6144174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.